(Q37788996)

23 August 2017

title

Pathogenesis and Treatment of Anti-MAG Neuropathy (English)

1 reference

23 August 2017

0 references

Marinos C. Dalakas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20842571

13 July 2024

language of work or name

1 reference

1 March 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s11940-010-0065-x.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11940-010-0065-X

http://link.springer.com/article/10.1007/s11940-010-0065-x/fulltext.html

13 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11940-010-0065-X

http://link.springer.com/content/pdf/10.1007/s11940-010-0065-x

13 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11940-010-0065-X

Current treatment options in neurology

13 July 2024

published in

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

71-83

1 reference

Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11940-010-0065-X

High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-010-0065-X

Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy

21 January 2018

1 reference

12 December 2020

Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens?

1 reference

12 December 2020

Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance.

1 reference

12 December 2020

A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy

1 reference

12 December 2020

Neurosurgical treatment of tremor in anti-myelin-associated glycoprotein neuropathy

1 reference

12 December 2020

Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies

1 reference

12 December 2020

Multiple antibodies to nerve glycoconjugates in a patient with neuropathy and monoclonal IgA gammopathy

1 reference

12 December 2020

Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy.

1 reference

12 December 2020

Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies

1 reference

12 December 2020

Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update

1 reference

12 December 2020

Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management

1 reference

12 December 2020

Worsening after rituximab treatment in anti-mag neuropathy

1 reference

12 December 2020

IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside

1 reference

12 December 2020

Prevalence of monoclonal protein in peripheral neuropathy

1 reference

12 December 2020

Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies

1 reference

12 December 2020

Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins

1 reference

12 December 2020

Paraproteins in the spinal fluid of patients with paraproteinemic polyneuropathies

1 reference

12 December 2020

Peripheral neuropathy and anti-MAG antibodies

1 reference

12 December 2020

Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy

1 reference

12 December 2020

Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody

1 reference

12 December 2020

Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy

1 reference

12 December 2020

Treatment of dys-immune neuropathies.

1 reference

12 December 2020

Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins

1 reference

12 December 2020

A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy

1 reference

12 December 2020

Polyneuropathy with monoclonal gammopathy: Studies of 11 patients

1 reference

12 December 2020

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.

1 reference

12 December 2020

Chronic idiopathic ataxic neuropathy

1 reference

12 December 2020

1 reference

12 December 2020

Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M

1 reference

12 December 2020

Do anti-ganglioside antibodies cause human peripheral neuropathies?

1 reference

12 December 2020

Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies

1 reference

12 December 2020

LONG-TERM EFFECT OF RITUXIMAB IN ANTI-MAG POLYNEUROPATHY

1 reference

12 December 2020

Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG.

1 reference

12 December 2020

Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside

1 reference

12 December 2020

Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside

1 reference

12 December 2020

High-dose rituximab and anti-MAG-associated polyneuropathy

1 reference

12 December 2020

Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab

1 reference

12 December 2020

IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy

1 reference

12 December 2020

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies

1 reference

12 December 2020

Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy

1 reference

12 December 2020

Treatment of IgM antibody associated polyneuropathies using rituximab

1 reference

12 December 2020

Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti‐myelin‐associated glycoprotein

1 reference

12 December 2020

Treatment of polyneuropathy in Waldenstrom's macroglobulinemia: Role of paraproteinemia and immunologic studies

1 reference

12 December 2020

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve

1 reference

12 December 2020

Prevalence of monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

Successful treatment of IgM paraproteinaemic neuropathy with fludarabine

1 reference

12 December 2020

Critical reviews in neurobiology

4

3

301

N Latov

1988

1 reference

https://api.crossref.org/works/10.1007/S11940-010-0065-X

Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins

13 July 2024

series ordinal

13

1 reference

https://api.crossref.org/works/10.1007/S11940-010-0065-X

B cells as therapeutic targets in autoimmune neurological disorders

13 July 2024

series ordinal

40

1 reference

https://api.crossref.org/works/10.1007/S11940-010-0065-X

Practical considerations on the use of rituximab in autoimmune neurological disorders

13 July 2024

series ordinal

41

1 reference

https://api.crossref.org/works/10.1007/S11940-010-0065-X

13 July 2024

Identifiers

1 reference

23 August 2017

1 reference